Deutsche Bank
REGN icon

Deutsche Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Deutsche Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-150
Closed -$56K – 5568
2017
Q4 		$56K Buy
+150
New +$60.8K ﹤0.01% 4414
2017
Q1 		– Sell
-80
Closed -$29K – 5067
2016
Q4 		$29K Hold
80
– – ﹤0.01% 4502
2016
Q3 		$32K Buy
+80
New +$32.1K ﹤0.01% 4378

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Deutsche Bank's REGN Position: Q2 2026 in Review

Deutsche Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 17% in Q2 2026, selling an estimated $72.8M and leaving 518,409 shares worth $323M. The position accounts for 0.09% of the portfolio, ranked #201.

Deutsche Bank first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $590M in Q4 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Deutsche Bank held 518,409 shares of Regeneron Pharmaceuticals worth $323M as of Q2 2026.
  • Deutsche Bank sold 106,979 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $72.8M.
  • Regeneron Pharmaceuticals made up 0.09% of Deutsche Bank's portfolio in Q2 2026, its #201 holding.
  • Deutsche Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Regeneron Pharmaceuticals position peaked at $590M in Q4 2025.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.